Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential

Cell Growth and Differentiation

Volumn 8, Issue 12, 1997, Pages 1287-1295

  Irby, Rosalyn ^a   Mao, Weiguang ^a   Coppola, Domenico ^a   Jove, Richard ^a   Gamero, Ana ^a   Cuthbertson, David ^a   Fujita, Donald J ^b   Yeatman, Timothy J ^a,c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE KINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; ONCOGENE SRC; PHENOTYPE; PRIORITY JOURNAL;

CELL DIVISION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; PHENOTYPE; PROTO-ONCOGENE PROTEINS PP60(C-SRC); TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS;

EID: 0031471321     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Fearon, E., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
2. Yeatman, T., Cher, M., Mao, W., Wloch, M., and Tedesco, T. Identification of genetic alterations associated with the process of human experimental colon cancer liver metastasis in the nude mouse. Clin. Exp. Metastasis, 14: 246-252, 1996.
3. Talamonti, M. A., Roh, M. S., Curley, S. A., and Gallick, G. E. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J. Clin. Invest., 91: 53, 1991.
4. Bolen, J., Veillette, A., Schwartz, A., DeSeau, V., and Rosen, N. Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc. Natl. Acad. Sci. USA, 84: 2251-2255, 1987.
5. Bolen, J., Veillette, A., Schwartz, A., Deseau, V., and Rosen, N. Analysis of pp60c-src in human colon carcinoma and normal human colon mucosal cells. Oncogene Res., 1: 149-168, 1987.
6. Cartwright, C., Meisler, A., and Eckhart, W. Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc. Natl. Acad. Sci. USA, 87: 558-562, 1990.
7. Cartwright, C., Kamps, M., Meisler, A., Pipas, J., and Eckhart, W. pp60c-src activation in human colon carcinoma. J. Clin. Invest., 83: 2025-2033, 1989.
8. Cartwright, C., Coad, C., and Egbert, B. Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. J. Clin. Invest., 93: 509-515, 1994.
9. Termuhlen, P. M., Curley, S. A., Talamonti, M. S., Saboorian, M. H., and Gallick, G. E. Site-specific differences in pp60c-src activity in human colorectal metastases. J. Surg. Res., 54: 1993.
10. c-Yes in human colorectal liver metastases. Clin. Cancer Res., 2: 1397-1404, 1996.
11. Brown, M., and Cooper, J. Regulation, substrates and functions of src. Biochim. Biophys. Acta, 1287: 121-149, 1996.
12. Hamaguchi, M., Yamagata, S., Thant, A., Xiao, H., Iwata, H., Mazaki, T., and Hanafusa, H. Augmentation of metalloproteinase (gelatinase) activity secreted from Rous sarcoma virus-infected cells correlates with transforming activity of src. Oncogene, 10: 1037-1043, 1995.
13. Rak, J., Filmus, J., Finkenzeller, G., Grugel, S., Marme, D., and Kerbel, R. Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev., 14: 263-277, 1995.
14. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. Mutant ras oncogenes up-regulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
15. Mukhopadhyay, D., Tsiokas, L., Zhou, X., Foster, D., Brugge, J., and Sukhatme, V. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375: 577-581, 1995.
16. Staley, C., Parikh, N., and Gallick, G. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src. Cell Growth Differ., 8: 269-274, 1997.
17. Takahashi, Y., Kitadai, Y., Bucana C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
18. 527 is phosphorylated in pp60c-src: implications for regulation. Science (Washington DC), 231: 1431-1434, 1986.
19. Iba, H., Takeya, T., Cross, F. R., Hanafusa, T., and Hanafusa, H. Rous sarcoma virus variants that carry the cellular src gene instead of the viral src gene cannot transform chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA, 81: 4424-4428, 1984.
20. Maa, M., Leu, T., McCarley, D., Schatzman, R., and Parsons, S. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proc. Natl. Acad. Sci. USA, 92: 6981-6985, 1995.
21. Johnson, P., Coussens, P., Danko, A., and Shalloway, D. Overexpressed pp60c-src can induce focus formation without complete transformation of NIH 3T3 cells. Mol. Cell. Biol., 5: 1073-1083, 1985.
22. Shalloway, D., Coussens, P., and Yaciuk, P. Overexpression of the c-src protein does not induce transformation of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA, 87: 7071-7075, 1984.
23. Jove, R., and Hanafusa, H. Cell transformation by the viral src oncogene. Annu. Rev. Cell Biol., 3: 31-56, 1987.
24. Antczak, M., and Kung, H. Transformation of chicken embryo fibroblasts by direct DNA transfection of single oncogenes: comparative analyses of src, erbB, myc, and ras. J. Viral., 64: 1451-1458, 1990.
25. Bjorge, J., Bellagamba, C., Cheng, H., Tanaka, A., Wang, J., and Fujita, D. Characterization of two activated mutants of human pp60c-src that escape c-Src kinase regulation by distinct mechanisms. J. Biol. Chem., 270: 24222-24228, 1995.
26. Egan, S., Wright, J., Jarolim, L., Yanagihara, K., Bassin, R., and Greenberg, A. Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science (Washington DC), 238: 202-205, 1987.
27. Tatsuka, M., Ota, T., Yamagishi, N., Kashihara, Y., Wada, M., Matsuda, N., Mitsui, H., Seiki, M., and Odashima, S. Different metastatic potentials of ras- and src-transformed BALB/c 3T3 A31 variant cells. Mol. Carcinog., 15: 300-308, 1996.
28. Mao, W., Irby, R., Copola, D., Fu, L., Wloch, M., Turner, J., Yu, H., Garcia, R., Jove, R., and Yeatman, T. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene, in press, 1997.
29. Morikawa, K., Walker, S., Jessup, J., and Fidler, I. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res., 48: 1943-1948, 1988.
30. Morikawa, K., Walker, S., Nakajima, M., Pathak, S., Jessup, J., and Fidler, I. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res., 48: 6863-6871, 1988.
31. Shah, V., Kumar, S., and Zirvi, K. Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72-kDa gelatinase. In Vivo (Athens), 8: 321-326, 1994.
32. Witty, J., McDonnell, S., Newell, K., Cannon, P., Navre, M., Tressler, R., and Matrisian, L. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res., 54: 4805-4812, 1994.
33. Zirvi, K., Najjar, T., and Slomiany, B. Sensitivity of human colon tumor metastases to anticancer drugs in athymic (nude) mice. Cancer Lett., 72: 39-44, 1993.
34. Giavazzi, R., Campbell, D., Jessup, J., Cleary, K., and Fidler, I. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res., 46: 1928-1933, 1986.
35. Wang, P., Fromowitz, F., Koslow, M., Hagag, N., Johnson, B., and Viola, M. c-src structure in human cancers with elevated pp60c-src activity. Br. J. Cancer, 64: 531-533, 1991.
36. Nada, S., Okada, M., MacAuley, A., Cooper, J. A., and Nakagawa, H. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature (Lond.), 351: 69-72, 1991.
37. Reddy, S., Yaciuk, P., Kmiecik, T., Coussens, P., and Shalloway, D. v-src mutations outside the carboxyl-coding region are not sufficient to fully activate transformation by pp60c-src in NIH 3T3 cells. Mol. Cell. Biol., 8: 704-712, 1988.
38. Yaciuk, P., Cannella, M., and Shalloway, D. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities. Oncogene Res., 3: 207-212, 1988.
39. Shalloway, D., Johnson, P., Freed, E., Coulter, D., and Flood, W. J. Transformation of NIH 3T3 cells by cotransfection with c-src and nuclear oncogenes. Mol. Cell. Biol., 7: 3582-3590, 1987.
40. Jessup, J., Giavazzi, R., Campbell, D., Cleary, K., Morikawa, K., Hostetter, R., Atkinson, E., and Fidler, I. Metastatic potential of human colorectal carcinomas implanted into nude mice: prediction of clinical outcome in patients operated upon for cure. Cancer Res., 49: 6906-6910, 1989.
41. Jessup, J., Giavazzi, R., Campbell, D., Cleary, K., Morikawa, K., and Fidler, I. Growth potential of human colorectal carcinomas in nude mice: association with the preoperative serum concentration of carcinoembryonic antigen in patients. Cancer Res., 48: 1689-1692, 1988.
42. Mahvi, D. M., Burkholder, J. K., Turner, J., Culp, J., Malter, J. S., Sondel, P. M., and Yang, N-S. Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine. Hum. Gene Ther., 7: 1535-1543, 1996.
43. Sambrook, J., Fritch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Second Ed. Nancy Ford (Ed.), pp. 737-750. Plainview, NY: Cold Spring Harbor Laboratory Press, 1989.